Taiwan FDA registration 1bc2a3e6064eb9edcff70035f6291ba6
"Commissioner" Group B Streptococcus Rapid Test Tablets (Unsterilized)
TW: "委達" B群鏈球菌快速檢測片 (未滅菌)
Taiwan·Risk Class 1·VEDA LAB·Registered Oct 21, 2011 – Oct 21, 2021CancelledRegistration details
- Analysis ID
- 1bc2a3e6064eb9edcff70035f6291ba6
- Customs Code
- DHA04401096906
Company information
- Manufacturer
- VEDA LAB
- Manufacturer Country
- France
- Authorized Representative
- RAFA INTERNATIONAL CORP.
Product details
- Intended Use
- Restriction of medical device management methods Streptococcus belongs to the first level identification range of serum reagent (C.3740).
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3740 鏈球菌屬血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Oct 21, 2011
- Expiry Date
- Oct 21, 2021
- Cancellation Date
- Oct 06, 2023
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for "Commissioner" Group B Streptococcus Rapid Test Tablets (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 1bc2a3e6064eb9edcff70035f6291ba6 and manufactured by VEDA LAB. The authorized representative in Taiwan is RAFA INTERNATIONAL CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices